ESC 2012 Report – Low rates of stent thrombosis similar for zotarolimus – and sirolimus-eluting stents: The PROTECT study
by Bruce Sylvester – Researchers from the PROTECT(Patient Related OuTcomes with Endeavor versus Cypher Stenting Rates) study reported at ESC that rates of stent thrombosis at three years… read more.